Issue Date
2011-05Subjects
muscle precursor cellsatellite cell
IGF-I
myostatin
three-dimensional muscle constructs
hypertrophy
atrophy
ageing
cachexia
Akt
mTOR
MAPK
mafbx
murf
foxo
igfbp2
FAK
Metadata
Show full item recordAbstract
To highlight recent breakthroughs and controversies in the use of myoblast models to uncover cellular and molecular mechanisms regulating skeletal muscle hypertrophy and atrophy.Citation
Sharples, A. P. and Stewart, C. E. (2011) 'Myoblast models of skeletal muscle hypertrophy and atrophy', Current opinion in clinical nutrition and metabolic care, 14(3) pp. 230-236.PubMed ID
21460719Type
ArticleLanguage
enISSN
1473-6519ae974a485f413a2113503eed53cd6c53
10.1097/MCO.0b013e3283457ade
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
- Authors: Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ
- Issue date: 2001 Nov
- Role of IGF-I in skeletal muscle mass maintenance.
- Authors: Clemmons DR
- Issue date: 2009 Sep
- The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans.
- Authors: Sakuma K, Watanabe K, Hotta N, Koike T, Ishida K, Katayama K, Akima H
- Issue date: 2009 Oct
- Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining.
- Authors: Jespersen JG, Nedergaard A, Andersen LL, Schjerling P, Andersen JL
- Issue date: 2011 Apr
- Skeletal muscle hypertrophy and atrophy signaling pathways.
- Authors: Glass DJ
- Issue date: 2005 Oct